KYN-5356

KYN-5356 · Kynexis B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KYN-5356, covering 2024-12-04 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia [Phase 2]